Efficacy of lapatinib monotherapy on occult breast cancer presenting with cutaneous metastases: A case report
By A Mystery Man Writer
Description
The case of a 72-year-old female who identified a lymph node enlargement in the left axilla is reported in the present study. A lymph node biopsy revealed a metastatic adenocarcinoma of the axillary lymph node. Following various assessments, the patient was diagnosed with occult breast cancer and lymph node metastases, for which treatment was initiated. Trastuzumab monotherapy was administered as the patient was elderly, positive for the hepatitis B virus and exhibited the following immunostaining/immunohistochemical analysis results: Estrogen receptor (ER) negative (-), progesterone receptor (PgR) negative (-) and human epidermal growth factor receptor 2 (HER2) positive (3+). Breast ultrasonography was performed 10 months after the initial trastuzumab administration and the left axillary lymph node enlargement had reduced in size and severity. However, a skin rash (erythema) was observed encompassing the left breast and extending into the axilla. As determined by the result of a skin biopsy of this area, the patient was diagnosed with occult breast cancer with cutaneous metastases. The immunohistochemical analysis results obtained from the skin biopsy were similar to those obtained from the lymph nodes: ER (-), PgR (-) and HER2 (3+). Therefore, the patient was switched from trastuzumab to lapatinib monotherapy. The erythema completely disappeared after two months of treatment. At present (34 months following lapatinib monotherapy initiation) no new lesions or severe side‑effects have been observed.
Gynecological oncology (Section 7) - Clinical Gynecology
Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases. - Abstract - Europe PMC
20745 PDFs Review articles in ERYTHEMA
Breast cancer Nature Reviews Disease Primers
Frontiers A Need for More Molecular Profiling in Brain Metastases
Recent advancements in nanoconstructs for the theranostics
Cutaneous metastases. December 2010: Flat polypoid lesions of eczema
PDF) Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?
Frontiers Case Report: Response to Immunotherapy and Anti
Inflammatory Breast Cancer: The Disease, the Biology, the
Inflammatory and Locally Advanced Breast Cancer
Breast Cancer
PDF) Recurrent Her-2 positive occult breast cancer presenting with zosteriform cutaneous metastases: a case report
Effects of lapatinib monotherapy: results of a randomised phase II
from
per adult (price varies by group size)